Shares of Nurix Therapeutics, Inc. (NRIX) have gained 2.3% over the past four weeks to close the last trading session at 12.44,buttherecouldstillbeasolidupsideleftinthestockifshort−termpricetargetsofWallStreetanalystsareanyindication.Goingbythepricetargets,themeanestimateof30.28 indicates a potential upside of 143.4%.The average comprises 18 short-term price targets ranging from a low of 16.00toahighof41.00, with a standard deviation of $6.49. While the lowest estim ...